Keep Eyes on: Aruba Networks (NASDAQ:ARUN), Anika Therapeutics Inc. (NASDAQ:ANIK), UGI Corporation (NYSE:UGI), Pfizer Inc. (NYSE:PFE), ASML Holding NV (NASDAQ:ASML)


Aruba Networks Inc (NASDAQ:ARUN) reported Q2 EPS of $0.30, $0.03 better than the analyst estimate of $0.27. The company posted revs of $212.9 million, versus the consensus of $210.2 million. On Thursday shares of Aruba Networks, Inc. (NASDAQ:ARUN) closed at $22.61. Company’s sales growth for last 5 years was 29.60% and EPS growth for next 5 years is recorded as 18.73%.

Anika Therapeutics Inc. (NASDAQ:ANIK) appointed Glenn R. Larsen, PhD, as a new independent member of its board of directors. Anika Therapeutics Inc. (NASDAQ:ANIK) in last trading activity fell -11.61% to close at $39.96. Company weekly performance is -9.57% while its quarterly performance stands at -4.81%. Anika Therapeutics Inc. (NASDAQ:ANIK) is -23.87% away from its 52 week high.

On February 18, it was reported that, UGI Corporation (NYSE:UGI) one of the lead partners in the PennEast Pipeline Partners, which is planning a $1 billion, more than 100-mile pipeline through Pennsylvania and New Jersey, has announced plans for a second, smaller pipeline. UGI Energy Services LLC says it plans to build an approximately 35-mile pipeline to bring natural gas from the Marcellus Shale region in Pennsylvania to a planned 1,000-megawatt power generation facility near Shamokin Dam in Snyder County. On last trading day UGI Corporation (NYSE:UGI) fell -0.94% to close at $33.87. Its volatility for the week is 1.37% while volatility for the month is 2.11%. UGI’s sales growth for past 5 years was 7.60% and its EPS growth for past 5 years was 4.00%. UGI Corporation (NYSE:UGI) monthly performance is -11.06%.

A proposed $400 million deal to resolve a class action lawsuit accusing Pfizer Inc. (NYSE:PFE) of misleading investors about illegal off-label drug marketing was put on track for approval on Thursday, but not before a Manhattan federal judge asked pointed questions about the value of the deal and demanded a fresh round of opt-out notices for investors. On Thursday shares of Pfizer Inc. (NYSE:PFE) closed at $34.59. Company’s sales growth for last 5 years was 0.10% and EPS growth for next 5 years is recorded as 2.17%.

ASML Holding NV (NASDAQ:ASML) has earned an “A-” credit rating from Morningstar. The firm’s “A-” rating suggests that the company is a low default risk. They also gave their stock a one star rating. On last trading day ASML Holding NV (NASDAQ:ASML) fell -0.97% to close at $107.91. Its volatility for the week is 1.66% while volatility for the month is 1.47%. ASML’s sales growth for past 5 years was 29.70% and its EPS growth for past 5 years was 51.80%. ASML Holding NV (NASDAQ:ASML) monthly performance is 1.49%.


Leave a Reply

Your email address will not be published. Required fields are marked *